Pharmacological applications of inorganic complexes

被引:64
作者
Bakhtiar, R
Ochiai, EI
机构
[1] Stevens Inst Technol, Dept Chem & Chem Biol, Hoboken, NJ 07030 USA
[2] Juniata Coll, Dept Chem, Huntingdon, PA 16652 USA
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1999年 / 32卷 / 05期
关键词
metal complexes; bioinorganic chemistry; pharmacology; metabolism; bio-organometallic chemistry;
D O I
10.1016/S0306-3623(98)00223-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inorganic complexes have long been utilized for many therapeutic purposes. They were used or tried, perhaps because of the general notion that inorganic compounds (e.g., metal complexes) are toxic and a controlled use of such a compound may suppress some biological process. In this review, we briefly outline the properties of several selected groups of inorganic complexes and how they can affect biological systems and contribute to human pathologies. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:525 / 540
页数:16
相关论文
共 94 条
[1]   Boron neutron capture therapy of brain tumors: Past history, current status, and future potential [J].
Barth, RF ;
Soloway, AH ;
Brugger, RM .
CANCER INVESTIGATION, 1996, 14 (06) :534-550
[2]   NITRIC-OXIDE GENERATION FROM NITROPRUSSIDE BY VASCULAR TISSUE - EVIDENCE THAT REDUCTION OF THE NITROPRUSSIDE ANION AND CYANIDE LOSS ARE REQUIRED [J].
BATES, JN ;
BAKER, MT ;
GUERRA, R ;
HARRISON, DG .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 :S157-S165
[3]   High-throughput synthesis and direct screening for the discovery of novel hydrolytic metal complexes [J].
Berg, T ;
Vandersteen, AM ;
Janda, KD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (10) :1221-1224
[4]  
BernersPrice SJ, 1996, COORDIN CHEM REV, V151, P1
[5]   Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats [J].
Bhanot, S ;
Michoulas, A ;
McNeill, JH .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 153 (1-2) :205-209
[6]  
BOWDEN CL, 1995, J CLIN PSYCHIAT, V56, P25
[7]   Protection by organotellurium compounds against peroxynitrite-mediated oxidation and nitration reactions [J].
Briviba, K ;
Tamler, R ;
Klotz, LO ;
Engman, L ;
Cotgreave, IA ;
Sies, H .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) :817-823
[8]  
Calamai P, 1998, ANTI-CANCER DRUG DES, V13, P67
[9]  
CARPINELLI P, 1995, ANTI-CANCER DRUG DES, V10, P43
[10]   MODE OF ACTION OF PENTAVALENT ANTIMONIALS - SPECIFIC-INHIBITION OF TYPE-I DNA TOPOISOMERASE OF LEISHMANIA-DONOVANI [J].
CHAKRABORTY, AK ;
MAJUMDER, HK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (02) :605-611